From the data described in Additional file 3 , it was not possible to identify a clear trend of increase in the number of studies for rare disease medicines after the publication of the BPCCPRD.
← all excerpts
Initiatives to promote access to medicines after publication of the Brazilian Policy on the Comprehensive Care of People with Rare Diseases.
1
—
—